Literature DB >> 16864170

Loco regional failure pattern after lumpectomy and breast irradiation in 4,185 patients with T1 and T2 breast cancer. Implications for nodal irradiation.

Lorenzo Livi1, Fabiola Paiar, Gabriele Simontacchi, Raffaella Barca, Beatrice Detti, Simona Fondelli, Paolo Bastiani, Roberto Santini, Vieri Scotti, Simonetta Bianchi, Luigi Cataliotti, Valiano Mungai, Giampaolo Biti.   

Abstract

The aim of this study is to determinate incidence and risk factors for loco regional failure (LRR) (breast, supraclavicular, axillary and internal mammary nodes) and indications for nodal irradiation. From January 1980 to December 2001, 4,185 patients with T1-T2 breast cancer were treated with conservative surgery and whole breast radiotherapy without nodal irradiation at the University of Florence. The median age was 55 years (range 19-86). All patients were followed for a median of eight years (range 3 months to 20 years). Multivariate analysis showed as independent prognostic factors for isolated nodal relapse (NR) the presence of more than three positive lymph nodes (PAN) (p = 0.001), angiolymphatic invasion (p = 0.002) and pT2 (p = 0.02). However, only 4.8% of patients with more than three PAN developed NR as the only site of recurrence. Having one to three PAN was not associated with an increased risk of NR. We believe that it is not necessary to prescribe nodal irradiation to patients with negative or one to three PAN. Regarding patients with more than three PAN, the number of isolated NR is also small to routinely justify a node irradiation.

Entities:  

Mesh:

Year:  2006        PMID: 16864170     DOI: 10.1080/02841860600658211

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  6 in total

1.  Outcomes in Patients with pT1-T2, pN0-N1 Breast Cancer After Conservative Surgery and Whole-breast Radiotherapy.

Authors:  Marianna Trignani; Clelia DI Carlo; Carmen Cefalogli; Marianna Nuzzo; Lucia Anna Ursini; Luciana Caravatta; Francesca Perrotti; Marta DI Nicola; Ambra Pamio; Domenico Genovesi
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

2.  Axillary and supraclavicular recurrences are rare after axillary lymph node dissection in breast cancer.

Authors:  Elina T Siponen; Leila A Vaalavirta; Heikki Joensuu; Marjut H K Leidenius
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

3.  Postoperative periclavicular radiotherapy in breast cancer patients with 1-3 positive axillary lymph nodes. Outcome and morbidity.

Authors:  A Biancosino; M Bremer; J H Karstens; C Biancosino; A Meyer
Journal:  Strahlenther Onkol       Date:  2012-03-14       Impact factor: 3.621

4.  Supraclavicular failure after breast-conserving therapy in patients with four or more positive axillary lymph nodes when prophylactic supraclavicular irradiation is omitted.

Authors:  Yasushi Hamamoto; Masaaki Kataoka; Takatoshi Semba; Kotaro Uwatsu; Yoshifumi Sugawara; Takeshi Inoue; Shinya Sakai; Shoji Aono; Tadaaki Takahashi; Shogo Oda
Journal:  Jpn J Radiol       Date:  2009-06-25       Impact factor: 2.374

5.  Using nodal ratios to predict risk of regional recurrences in patients treated with breast conservation therapy with 4 or more positive lymph nodes.

Authors:  William Castrucci; Donald Lannin; Bruce G Haffty; Susan A Higgins; Meena S Moran
Journal:  ISRN Surg       Date:  2011-06-30

6.  Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study.

Authors:  Haeyoung Kim; Won Park; Jeong Il Yu; Doo Ho Choi; Seung Jae Huh; Yeon-Joo Kim; Eun Sook Lee; Keun Seok Lee; Han-Sung Kang; In Hae Park; Kyung Hwan Shin; Chan Woo Wee; Kyubo Kim; Kyung Ran Park; Yong Bae Kim; Sung Ja Ahn; Jong Hoon Lee; Jin Hee Kim; Mison Chun; Hyung-Sik Lee; Jung Soo Kim; Jihye Cha
Journal:  Cancer Res Treat       Date:  2017-01-04       Impact factor: 4.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.